Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gastric Cancer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    September 2025
  1. LIOU JM, Malfertheiner P, Hong TC, Cheng HC, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.
    Gut. 2025 Sep 5:gutjnl-2025-336027. doi: 10.1136/gutjnl-2025-336027.
    PubMed     Abstract available


    June 2025
  2. TOGASAKI K, Sato T
    Decoding intestinal metaplasia: a step towards understanding gastric tumourigenesis.
    Gut. 2025 Jun 20:gutjnl-2024-334234. doi: 10.1136/gutjnl-2024-334234.
    PubMed    


  3. HUANG W, Li Y, Li J
    Enhancing non-invasive early detection of gastric cancer: a critical reflection on exosome ncRNA and machine learning.
    Gut. 2025 Jun 19:gutjnl-2025-335183. doi: 10.1136/gutjnl-2025-335183.
    PubMed    



  4. Retraction: Unleashing the potential of exosome ncRNAs for early gastric cancer detection-a critical appraisal of machine learning approaches.
    Gut. 2025 Jun 17:gutjnl-2025-334909.ret. doi: 10.1136/gutjnl-2025-334909.
    PubMed    


    April 2025
  5. LEE YC
    Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
    Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
    PubMed    


  6. YAMADA H, Abe S, Charvat H, Ando T, et al
    Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study.
    Gut. 2025 Apr 15:gutjnl-2025-335039. doi: 10.1136/gutjnl-2025-335039.
    PubMed     Abstract available


  7. KEMP LJS, Monster JL, Wood CS, Moers M, et al
    Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression.
    Gut. 2025 Apr 1:gutjnl-2024-334589. doi: 10.1136/gutjnl-2024-334589.
    PubMed     Abstract available


    March 2025
  8. GUO X, Wang W, Cheng X, Song Q, et al
    Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer.
    Gut. 2025 Mar 20:gutjnl-2024-333657. doi: 10.1136/gutjnl-2024-333657.
    PubMed     Abstract available


  9. YUE SSK, Tong Y, Siu HC, Ho SL, et al
    Divergent lineage trajectories and genetic landscapes in human gastric intestinal metaplasia organoids associated with early neoplastic progression.
    Gut. 2025;74:522-538.
    PubMed     Abstract available


    February 2025
  10. ZENG X
    Unleashing the potential of exosome ncRNAs for early gastric cancer detection-a critical appraisal of machine learning approaches.
    Gut. 2025 Feb 23:gutjnl-2025-334909. doi: 10.1136/gutjnl-2025-334909.
    PubMed    


  11. SHIMURA M, Matsuo J, Pang S, Jangphattananont N, et al
    IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.
    Gut. 2025;74:364-386.
    PubMed     Abstract available


    January 2025
  12. CAI ZR, Zheng YQ, Hu Y, Ma MY, et al
    Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study.
    Gut. 2025 Jan 3:gutjnl-2024-333522. doi: 10.1136/gutjnl-2024-333522.
    PubMed     Abstract available


    November 2024
  13. LEE SH, Lee D, Choi J, Oh HJ, et al
    Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages.
    Gut. 2024 Nov 23:gutjnl-2024-332901. doi: 10.1136/gutjnl-2024-332901.
    PubMed     Abstract available


  14. LI Y, Zheng Y, Huang J, Nie RC, et al
    CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.
    Gut. 2024 Nov 12:gutjnl-2024-333617. doi: 10.1136/gutjnl-2024-333617.
    PubMed     Abstract available


    September 2024
  15. DINIS-RIBEIRO M, Shah S, El-Serag H, Banks M, et al
    The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
    Gut. 2024;73:1607-1617.
    PubMed     Abstract available


  16. LEJA M
    Where are we with gastric cancer screening in Europe in 2024?
    Gut. 2024 Sep 4:gutjnl-2024-332705. doi: 10.1136/gutjnl-2024-332705.
    PubMed     Abstract available


    August 2024
  17. BEATON DR, Sharp L, Lu L, Trudgill NJ, et al
    Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database.
    Gut. 2024;73:1421-1430.
    PubMed     Abstract available


    July 2024
  18. HUANG XB, Huang Q, Jiang MC, Zhong Q, et al
    KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis.
    Gut. 2024 Jul 5:gutjnl-2023-331111. doi: 10.1136/gutjnl-2023-331111.
    PubMed     Abstract available


    June 2024
  19. ZENG R, Gou H, Lau HCH, Yu J, et al
    Stomach microbiota in gastric cancer development and clinical implications.
    Gut. 2024 Jun 17:gutjnl-2024-332815. doi: 10.1136/gutjnl-2024-332815.
    PubMed     Abstract available


    April 2024
  20. ZHANG F, Sahu V, Peng K, Wang Y, et al
    Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Gut. 2024 Apr 15:gutjnl-2023-329686. doi: 10.1136/gutjnl-2023-329686.
    PubMed     Abstract available


    February 2024
  21. RUGGE M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, et al
    RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates.
    Gut. 2024;73:407-441.
    PubMed     Abstract available


    January 2024
  22. TAKEUCHI C, Yamashita S, Liu YY, Takeshima H, et al
    Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation.
    Gut. 2024;73:255-267.
    PubMed     Abstract available


    December 2023
  23. LATORRE G, Silva F, Montero I, Bustamante M, et al
    Comparison of OLGA and OLGIM as predictors of gastric cancer in a Latin American population: the ECHOS Study.
    Gut. 2023 Dec 26:gutjnl-2023-331059. doi: 10.1136/gutjnl-2023-331059.
    PubMed    


  24. MORAIS R, Libanio D, Dinis Ribeiro M, Ferreira A, et al
    Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score.
    Gut. 2023;73:105-117.
    PubMed     Abstract available


  25. TAN P, Chu Y
    Single-cell profiling of gastric cardia adenocarcinoma reveals drivers of cancer stemness and therapeutic targets.
    Gut. 2023;73:1-2.
    PubMed    


  26. WANG Z, Wang Q, Chen C, Zhao X, et al
    NNMT enriches for AQP5(+) cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma.
    Gut. 2023;73:63-77.
    PubMed     Abstract available


    November 2023
  27. LAHNER E, Dilaghi E, Dottori L, Annibale B, et al
    Not all that is corpus restricted is necessarily autoimmune.
    Gut. 2023;72:2384-2385.
    PubMed    


    August 2023
  28. LEJA M
    Potential of personalised approaches in gastric cancer prevention.
    Gut. 2023 Aug 27:gutjnl-2023-330215. doi: 10.1136/gutjnl-2023-330215.
    PubMed    


    July 2023
  29. XU Z, Huang Y, Hu C, Du L, et al
    Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study.
    Gut. 2023 Jul 17:gutjnl-2023-330045. doi: 10.1136/gutjnl-2023-330045.
    PubMed     Abstract available


  30. CAO LL, Lu H, Soutto M, Bhat N, et al
    Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-gamma signalling.
    Gut. 2023 Jul 4:gutjnl-2022-329134. doi: 10.1136/gutjnl-2022-329134.
    PubMed     Abstract available


    May 2023
  31. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    PubMed     Abstract available


  32. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    PubMed    


    April 2023
  33. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available


  34. FAN Y, Li Y, Yao X, Jin J, et al
    Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
    Gut. 2023;72:624-637.
    PubMed     Abstract available


    March 2023
  35. XU C, Huang KK, Law JH, Chua JS, et al
    Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
    Gut. 2023 Mar 14:gutjnl-2022-328332. doi: 10.1136/gutjnl-2022-328332.
    PubMed     Abstract available


    February 2023
  36. RUGGE M, Genta RM, Malfertheiner P, Graham DY, et al
    Gastric cancer risk in autoimmune gastritis: evidence versus opinion.
    Gut. 2023 Feb 27:gutjnl-2023-329618. doi: 10.1136/gutjnl-2023-329618.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.